Clinical Trials on Thrombotic and Bleeding Events in Australia

Total 304 results

Daniel Zimpfer, MD

Terminated

Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)

Thrombosis | Bleeding

Austria
ThromboGenics
BioInvent International AB

Completed

Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery

Prophylaxis of Venous Thromboembolic Events

Austria, Netherlands, Belgium, Bulgaria, Hungary, Latvia, Poland, Russian Federation, Ukraine
Population Health Research Institute

Completed

PeriOperative ISchemic Evaluation-3 Trial (POISE-3)

Venous Thrombosis | Arterial Thrombosis | Perioperative Bleeding

Spain, United States, Germany, Hong Kong, Australia, New Zealand, Canada, United Kingdom, Austria, Belgium, Malaysia, Brazil, Netherlands, China, Pakistan, Russian Federation, France, Chile, Denmark, India, Italy, Poland, South Africa
Monash University
CSL Behring; National Blood Authority; New Zealand Blood Service; Department of...

Recruiting

Australian and New Zealand Massive Transfusion Registry (ANZ-MTR)

Trauma | Gastrointestinal Bleeding | Liver Transplant | Cardiothoracic Surgery | Vascular Surgery | Massive Transfusion | Obstetric Bleeding

Australia
Bristol-Myers Squibb
Pfizer

Completed

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

Thromboembolism

United States, Canada, Mexico, Israel, Australia
AstraZeneca

Terminated

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events (EXTEND)

Thromboembolism

Sweden, France, Mexico, Poland, South Africa, Spain, Germany, Hungary, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Switzerland
Optimed Medizinische Instrumente GmbH

Completed

Treatment of the Postthrombotic Syndrome With the Oblique Stent - TOPOS Study

Post-thrombotic Syndrome | Iliac Vein Compression Syndrome

Switzerland, Austria, Germany, Netherlands
Chinese University of Hong Kong
Beijing Friendship Hospital; The First Affiliated Hospital of Soochow University and other collaborators

Completed

Over-the-scope Clips and Standard Treatments in Endoscopic Control of Acute Bleeding From Non-variceal Upper GI Causes

Acute Upper Gastrointestinal Bleeding | Tumor Bleeding

Hong Kong, China, Australia
Western Sydney Local Health District

Completed

Systematic Description of the Post EMR Defect

Endoscopic Mucosal Resection | Delayed Bleeding Post EMR | Large Laterally Spreading Lesion in the Colon

Australia
Novo Nordisk A/S

Completed

Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients

Trauma | Acquired Bleeding Disorder

Germany, Austria, Israel, France, Canada, Singapore, South Africa, Australia, United Kingdom
Sydney Centre for Reproductive Health Research
Merck Sharp & Dohme LLC

Unknown

A New Treatment Option for Heavy Menstrual Bleeding

Menorrhagia

Australia
Medical University of Graz

Completed

Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery (BIANCA)

Postoperative Bleeding

Austria
Chinese University of Hong Kong

Recruiting

Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients (NOAC-GAP)

Upper Gastrointestinal Bleeding

Singapore, Hong Kong, Australia
University Hospital Inselspital, Berne

Completed

Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis (INVEST)

Drug-Eluting Stents | Coronary Thrombosis | Tomography, Optical Coherence

Austria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
Melbourne Health
Sanofi; National Heart Foundation, Australia

Terminated

The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.

Deep Vein Thrombosis

Australia
Medical University of Graz

Active, not recruiting

Factor XIII Activity in Gastrointestinal Bleedings

Gastro Intestinal Bleeding

Austria
Medical University of Vienna

Completed

Side Effects of Transesophageal Echocardiography

Upper Gastrointestinal Bleeding

Austria
Sanofi

Completed

Venous Thromboembolism Taskforce Audit Program

Venous Thrombosis

Australia
Medical University of Graz
Novo Nordisk A/S; CSL Behring

Completed

Reversibility of Dual Antiplatelet Therapy by Platelets

Bleeding

Austria
Ethicon, Inc.

Completed

The Severe Soft Tissue Bleeding Study

Soft Tissue Bleeding

New Zealand, United Kingdom, Australia, Germany
Family Planning Association New South Wales
Merck Sharp & Dohme LLC

Unknown

New Treatments for Troublesome Bleeding in Implanon Users

Menstrual Problem

Australia
Medical University of Graz

Completed

Platelet Inhibition and Bleeding in Patients Undergoing Emergent Cardiac Surgery

Bleeding

Austria
Medical University of Vienna

Completed

Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy (ENDOvsTIPS)

Cirrhosis | Gastrointestinal Hemorrhage | Encephalopathy | Variceal Bleeding

Austria
Merit Medical Systems, Inc.

Recruiting

EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging

Hemorrhage | Bleeding Hemorrhage

France, Australia
Bayer

Completed

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Metrorrhagia

Sweden, Germany, Poland, Finland, Australia, Czech Republic, Hungary, Netherlands, Ukraine, United Kingdom
Novo Nordisk A/S

Completed

Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease

Acquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary Bypass

Australia
CSL Limited

Completed

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Idiopathic Thrombocytopenic Purpura (ITP)

Australia
Veniti

Withdrawn

VERITAS: An Evaluation of the Veniti Vidi Retrievable Inferior Vena Cava Filter System in Patients at Risk for Pulmonary Embolism (VERITAS)

Deep Vein Thrombosis | Pulmonary Embolus

New Zealand, Australia
Novo Nordisk A/S

Completed

Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation

Acquired Bleeding Disorder | Bleeding During/Following Surgery

Germany, Sweden, United Kingdom, Spain, Canada, Australia, France
Sirius Therapeutics Co., Ltd.

Recruiting

A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants

Thrombosis

Australia
Novo Nordisk A/S

Completed

Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation

Acquired Bleeding Disorder | Bleeding During/Following Surgery

Israel, Sweden, United Kingdom, Germany, Switzerland, France, Spain, Italy, Thailand, Denmark, United States, Poland, Finland, Singapore, Australia, Austria
Medical University of Vienna

Completed

Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion

Central Venous Catheter Thrombosis

Austria
Sanofi

Terminated

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation (BOREALIS-AF)

Atrial Fibrillation

South Africa, Thailand, Chile, Guatemala, Ukraine, United States, Argentina, Australia, Austria, Belarus, Brazil, Bulgaria, Canada, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Greece, India, ... and more
Medical University of Vienna

Recruiting

Safety and Feasibility of Argatroban as Anticoagulant in Adults With ECMO

Extracorporeal Membrane Oxygenation Complication | Anticoagulants and Bleeding Disorders

Austria
Monash Medical Centre
Middlemore Hospital, New Zealand; Prince of Wales Hospital, Sydney; Auckland... and other collaborators

Unknown

Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis (TWISTER)

Venous Thrombosis | Pulmonary Embolism

Australia, New Zealand
Takeda
Theravance Biopharma

Completed

A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance

Enteral Feeding Intolerance

Australia
University of Sydney

Recruiting

Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema (NIRVO)

Retinal Vein Occlusion | Macula Edema

Australia
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer

Venous Thrombosis | Deep Vein Thrombosis

Italy, Austria, Brazil, Hungary, Netherlands, South Africa, Israel, Australia, Germany
Bristol-Myers Squibb

Completed

Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study

Deep-Vein Thrombosis

Netherlands, Austria, Italy, South Africa, Israel, United States, France, Australia, Poland, Sweden, Czech Republic
Bayside Health
National Health and Medical Research Council, Australia

Recruiting

Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery (TRIGS)

Bleeding | Anesthesia | Gastrointestinal Complication | Healthcare Associated Infection | Infection Wound

Australia
Medical University of Vienna

Recruiting

Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism (AURECpro)

Recurrent Venous Thrombosis

Austria
Medical University of Vienna

Completed

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Retinal Vein Occlusion

Austria
Protalex, Inc.

Terminated

Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

Idiopathic Thrombocytopenic Purpura (ITP)

Australia, New Zealand
Medical University of Vienna

Completed

Erythropoietin and Platelet Activation Markers

Hypertension | Thrombosis

Austria
Rudolf Foundation Clinic

Completed

The ROVO Study: Radial Optic Neurotomy for CVO

Central Retinal Vein Occlusion

Austria
Mallinckrodt

Completed

A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery

Surgical Bleeding

Germany, Austria
Sanofi

Completed

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs (EQUINOX)

Deep Venous Thrombosis

France, Mexico, Turkey, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Israel, Netherlands, New Zealand, Poland, Russian Federation, South Africa, Spain
Medical University of Vienna

Completed

Risk Factors of Minor Head Injury

Traumatic Brain Injury | Minor Head Injury | Intracranial Bleeding

Austria
Bayer

Completed

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis (CONVERT)

Hemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic Events

Spain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal
Ablynx, a Sanofi company

Completed

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (TITAN)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Austria, Belgium, France, Germany, Israel, Italy, Spain, Switzerland, United Kingdom, Bulgaria, Romania, Australia

Clinical Trials on Thrombotic and Bleeding Events in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations